Results 111 to 120 of about 98,848 (186)

Melanoma: Pathogenesis and Targeted Therapy. [PDF]

MedComm (2020)
Fu Y, Liu J, Mo Z, Wang B, Deng Y, Jiang Y.   +5 more
europepmc   +1 more source

Un-sweetening the deal: targeting glucose metabolism in brain arteriovenous malformations. [PDF]

EMBO Mol Med
Rudnicki M, Haas TL.
europepmc   +1 more source

MEK Inhibition Reduces Vascular Malformations and Gene Dysregulation in NRAS^Q61R Human Endothelial Cells. [PDF]

Pediatr Blood Cancer
Alharbi S, Wagner A, Merkle S, Pastura P, McDaniel CG, Fox D, Xu Y, Cras TDL.   +7 more
europepmc   +1 more source

GAB2 regulates lipid metabolism by activating the MEK/ERK/c-Myc pathway: impact on renal cell carcinoma progression. [PDF]

Eur J Med Res
Zhang W, Fei X, Qin P, Sun Y, Zhu Z, Huang N, Li X, Li Z, Liu T.   +8 more
europepmc   +1 more source

Lung adenocarcinoma with KRAS-Q61H: clinicopathologic features, diagnostics, and the evolving treatment landscape. [PDF]

Front Oncol
Serafimidis I.
europepmc   +1 more source

Window of opportunity study measuring defactinib and avutometinib delivery in glioblastomas. [PDF]

Cancer Chemother Pharmacol
Del Valle MM, Colon EM, Kettimuthu K, Maner-Smith K, Olson JJ, Kucheryavykh LY.   +5 more
europepmc   +1 more source

When Erdheim-Chester Disease Reaches the Pectoral Muscle. [PDF]

Eur J Case Rep Intern Med
Carton N, Acet Öztürk NA, Özşen M, Aydın-Güçlü Ö, Ursavaş A.   +4 more
europepmc   +1 more source

MEK Inhibitor AZD8330 [PDF]

, 2020
openaire   +1 more source

Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies. [PDF]

Biomed Pharmacother
Nair HB, Subramani R, Lakshmanaswamy R.
europepmc   +1 more source

MEK solvent power... [PDF]

Chemical & Engineering News Archive, 1960
openaire   +1 more source